0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurovascular Interventional Devices Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-16M14255
Home | Market Reports | Health| Health Conditions
Global Neurovascular Interventional Devices Market Research Report 2023
BUY CHAPTERS

Global Neurovascular Interventional Devices Market Research Report 2025

Code: QYRE-Auto-16M14255
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurovascular Interventional Devices Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Neurovascular Interventional Devices Market

Neurovascular Interventional Devices Market

The global market for Neurovascular Interventional Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurovascular Interventional Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Interventional Devices.
The Neurovascular Interventional Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurovascular Interventional Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Interventional Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurovascular Interventional Devices Market Report

Report Metric Details
Report Name Neurovascular Interventional Devices Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company W.L. Gore & Associates, Abbott Laboratories, Stryker Corporation, Medtronic PLC, Terumo Corporation, Johnson & Johnson, Penumbra, Inc., Boston Scientific Corporation, Merit Medical Systems, Inc., Microport Scientific Corporation, Cardinal Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurovascular Interventional Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Neurovascular Interventional Devices Market report?

Ans: The main players in the Neurovascular Interventional Devices Market are W.L. Gore & Associates, Abbott Laboratories, Stryker Corporation, Medtronic PLC, Terumo Corporation, Johnson & Johnson, Penumbra, Inc., Boston Scientific Corporation, Merit Medical Systems, Inc., Microport Scientific Corporation, Cardinal Health

What are the Application segmentation covered in the Neurovascular Interventional Devices Market report?

Ans: The Applications covered in the Neurovascular Interventional Devices Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Neurovascular Interventional Devices Market report?

Ans: The Types covered in the Neurovascular Interventional Devices Market report are Embolization Coils, Carotid Stents, Intracranial Stents, Flow Diverters, Intrasaccular Devices, Others

Recommended Reports

Neurovascular Devices

Interventional Catheters

Neurological Devices

1 Neurovascular Interventional Devices Market Overview
1.1 Product Definition
1.2 Neurovascular Interventional Devices by Type
1.2.1 Global Neurovascular Interventional Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Embolization Coils
1.2.3 Carotid Stents
1.2.4 Intracranial Stents
1.2.5 Flow Diverters
1.2.6 Intrasaccular Devices
1.2.7 Others
1.3 Neurovascular Interventional Devices by Application
1.3.1 Global Neurovascular Interventional Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Neurovascular Interventional Devices Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Interventional Devices Revenue 2020-2031
1.4.2 Global Neurovascular Interventional Devices Sales 2020-2031
1.4.3 Global Neurovascular Interventional Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neurovascular Interventional Devices Market Competition by Manufacturers
2.1 Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neurovascular Interventional Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neurovascular Interventional Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neurovascular Interventional Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurovascular Interventional Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Interventional Devices, Product Type & Application
2.7 Global Key Manufacturers of Neurovascular Interventional Devices, Date of Enter into This Industry
2.8 Global Neurovascular Interventional Devices Market Competitive Situation and Trends
2.8.1 Global Neurovascular Interventional Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurovascular Interventional Devices Players Market Share by Revenue
2.8.3 Global Neurovascular Interventional Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurovascular Interventional Devices Market Scenario by Region
3.1 Global Neurovascular Interventional Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neurovascular Interventional Devices Sales by Region: 2020-2031
3.2.1 Global Neurovascular Interventional Devices Sales by Region: 2020-2025
3.2.2 Global Neurovascular Interventional Devices Sales by Region: 2026-2031
3.3 Global Neurovascular Interventional Devices Revenue by Region: 2020-2031
3.3.1 Global Neurovascular Interventional Devices Revenue by Region: 2020-2025
3.3.2 Global Neurovascular Interventional Devices Revenue by Region: 2026-2031
3.4 North America Neurovascular Interventional Devices Market Facts & Figures by Country
3.4.1 North America Neurovascular Interventional Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neurovascular Interventional Devices Sales by Country (2020-2031)
3.4.3 North America Neurovascular Interventional Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurovascular Interventional Devices Market Facts & Figures by Country
3.5.1 Europe Neurovascular Interventional Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neurovascular Interventional Devices Sales by Country (2020-2031)
3.5.3 Europe Neurovascular Interventional Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Interventional Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Neurovascular Interventional Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neurovascular Interventional Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Neurovascular Interventional Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurovascular Interventional Devices Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Interventional Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neurovascular Interventional Devices Sales by Country (2020-2031)
3.7.3 Latin America Neurovascular Interventional Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Interventional Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Interventional Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neurovascular Interventional Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurovascular Interventional Devices Sales by Type (2020-2031)
4.1.1 Global Neurovascular Interventional Devices Sales by Type (2020-2025)
4.1.2 Global Neurovascular Interventional Devices Sales by Type (2026-2031)
4.1.3 Global Neurovascular Interventional Devices Sales Market Share by Type (2020-2031)
4.2 Global Neurovascular Interventional Devices Revenue by Type (2020-2031)
4.2.1 Global Neurovascular Interventional Devices Revenue by Type (2020-2025)
4.2.2 Global Neurovascular Interventional Devices Revenue by Type (2026-2031)
4.2.3 Global Neurovascular Interventional Devices Revenue Market Share by Type (2020-2031)
4.3 Global Neurovascular Interventional Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neurovascular Interventional Devices Sales by Application (2020-2031)
5.1.1 Global Neurovascular Interventional Devices Sales by Application (2020-2025)
5.1.2 Global Neurovascular Interventional Devices Sales by Application (2026-2031)
5.1.3 Global Neurovascular Interventional Devices Sales Market Share by Application (2020-2031)
5.2 Global Neurovascular Interventional Devices Revenue by Application (2020-2031)
5.2.1 Global Neurovascular Interventional Devices Revenue by Application (2020-2025)
5.2.2 Global Neurovascular Interventional Devices Revenue by Application (2026-2031)
5.2.3 Global Neurovascular Interventional Devices Revenue Market Share by Application (2020-2031)
5.3 Global Neurovascular Interventional Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 W.L. Gore & Associates
6.1.1 W.L. Gore & Associates Company Information
6.1.2 W.L. Gore & Associates Description and Business Overview
6.1.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
6.1.5 W.L. Gore & Associates Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Company Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Company Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Medtronic PLC
6.4.1 Medtronic PLC Company Information
6.4.2 Medtronic PLC Description and Business Overview
6.4.3 Medtronic PLC Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
6.4.5 Medtronic PLC Recent Developments/Updates
6.5 Terumo Corporation
6.5.1 Terumo Corporation Company Information
6.5.2 Terumo Corporation Description and Business Overview
6.5.3 Terumo Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
6.5.5 Terumo Corporation Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Penumbra, Inc.
6.7.1 Penumbra, Inc. Company Information
6.7.2 Penumbra, Inc. Description and Business Overview
6.7.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
6.7.5 Penumbra, Inc. Recent Developments/Updates
6.8 Boston Scientific Corporation
6.8.1 Boston Scientific Corporation Company Information
6.8.2 Boston Scientific Corporation Description and Business Overview
6.8.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
6.8.5 Boston Scientific Corporation Recent Developments/Updates
6.9 Merit Medical Systems, Inc.
6.9.1 Merit Medical Systems, Inc. Company Information
6.9.2 Merit Medical Systems, Inc. Description and Business Overview
6.9.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
6.9.5 Merit Medical Systems, Inc. Recent Developments/Updates
6.10 Microport Scientific Corporation
6.10.1 Microport Scientific Corporation Company Information
6.10.2 Microport Scientific Corporation Description and Business Overview
6.10.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
6.10.5 Microport Scientific Corporation Recent Developments/Updates
6.11 Cardinal Health
6.11.1 Cardinal Health Company Information
6.11.2 Cardinal Health Description and Business Overview
6.11.3 Cardinal Health Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
6.11.5 Cardinal Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Interventional Devices Industry Chain Analysis
7.2 Neurovascular Interventional Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Interventional Devices Production Mode & Process Analysis
7.4 Neurovascular Interventional Devices Sales and Marketing
7.4.1 Neurovascular Interventional Devices Sales Channels
7.4.2 Neurovascular Interventional Devices Distributors
7.5 Neurovascular Interventional Devices Customer Analysis
8 Neurovascular Interventional Devices Market Dynamics
8.1 Neurovascular Interventional Devices Industry Trends
8.2 Neurovascular Interventional Devices Market Drivers
8.3 Neurovascular Interventional Devices Market Challenges
8.4 Neurovascular Interventional Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Neurovascular Interventional Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neurovascular Interventional Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neurovascular Interventional Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neurovascular Interventional Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neurovascular Interventional Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neurovascular Interventional Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neurovascular Interventional Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neurovascular Interventional Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neurovascular Interventional Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neurovascular Interventional Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Neurovascular Interventional Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neurovascular Interventional Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Interventional Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neurovascular Interventional Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neurovascular Interventional Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Neurovascular Interventional Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Neurovascular Interventional Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Neurovascular Interventional Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Neurovascular Interventional Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neurovascular Interventional Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Neurovascular Interventional Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neurovascular Interventional Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Neurovascular Interventional Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neurovascular Interventional Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Neurovascular Interventional Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Neurovascular Interventional Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neurovascular Interventional Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neurovascular Interventional Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neurovascular Interventional Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Neurovascular Interventional Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Neurovascular Interventional Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neurovascular Interventional Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neurovascular Interventional Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neurovascular Interventional Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Neurovascular Interventional Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Neurovascular Interventional Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neurovascular Interventional Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neurovascular Interventional Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neurovascular Interventional Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Neurovascular Interventional Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Neurovascular Interventional Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neurovascular Interventional Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neurovascular Interventional Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neurovascular Interventional Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Neurovascular Interventional Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Neurovascular Interventional Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Neurovascular Interventional Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Neurovascular Interventional Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neurovascular Interventional Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neurovascular Interventional Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Neurovascular Interventional Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Neurovascular Interventional Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Neurovascular Interventional Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Neurovascular Interventional Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Neurovascular Interventional Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Neurovascular Interventional Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Neurovascular Interventional Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Neurovascular Interventional Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neurovascular Interventional Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neurovascular Interventional Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Neurovascular Interventional Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Neurovascular Interventional Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Neurovascular Interventional Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. W.L. Gore & Associates Company Information
 Table 71. W.L. Gore & Associates Description and Business Overview
 Table 72. W.L. Gore & Associates Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. W.L. Gore & Associates Neurovascular Interventional Devices Product
 Table 74. W.L. Gore & Associates Recent Developments/Updates
 Table 75. Abbott Laboratories Company Information
 Table 76. Abbott Laboratories Description and Business Overview
 Table 77. Abbott Laboratories Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Laboratories Neurovascular Interventional Devices Product
 Table 79. Abbott Laboratories Recent Developments/Updates
 Table 80. Stryker Corporation Company Information
 Table 81. Stryker Corporation Description and Business Overview
 Table 82. Stryker Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Stryker Corporation Neurovascular Interventional Devices Product
 Table 84. Stryker Corporation Recent Developments/Updates
 Table 85. Medtronic PLC Company Information
 Table 86. Medtronic PLC Description and Business Overview
 Table 87. Medtronic PLC Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Medtronic PLC Neurovascular Interventional Devices Product
 Table 89. Medtronic PLC Recent Developments/Updates
 Table 90. Terumo Corporation Company Information
 Table 91. Terumo Corporation Description and Business Overview
 Table 92. Terumo Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Terumo Corporation Neurovascular Interventional Devices Product
 Table 94. Terumo Corporation Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Neurovascular Interventional Devices Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Penumbra, Inc. Company Information
 Table 101. Penumbra, Inc. Description and Business Overview
 Table 102. Penumbra, Inc. Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Penumbra, Inc. Neurovascular Interventional Devices Product
 Table 104. Penumbra, Inc. Recent Developments/Updates
 Table 105. Boston Scientific Corporation Company Information
 Table 106. Boston Scientific Corporation Description and Business Overview
 Table 107. Boston Scientific Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Boston Scientific Corporation Neurovascular Interventional Devices Product
 Table 109. Boston Scientific Corporation Recent Developments/Updates
 Table 110. Merit Medical Systems, Inc. Company Information
 Table 111. Merit Medical Systems, Inc. Description and Business Overview
 Table 112. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product
 Table 114. Merit Medical Systems, Inc. Recent Developments/Updates
 Table 115. Microport Scientific Corporation Company Information
 Table 116. Microport Scientific Corporation Description and Business Overview
 Table 117. Microport Scientific Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Microport Scientific Corporation Neurovascular Interventional Devices Product
 Table 119. Microport Scientific Corporation Recent Developments/Updates
 Table 120. Cardinal Health Company Information
 Table 121. Cardinal Health Description and Business Overview
 Table 122. Cardinal Health Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Cardinal Health Neurovascular Interventional Devices Product
 Table 124. Cardinal Health Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Neurovascular Interventional Devices Distributors List
 Table 128. Neurovascular Interventional Devices Customers List
 Table 129. Neurovascular Interventional Devices Market Trends
 Table 130. Neurovascular Interventional Devices Market Drivers
 Table 131. Neurovascular Interventional Devices Market Challenges
 Table 132. Neurovascular Interventional Devices Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neurovascular Interventional Devices
 Figure 2. Global Neurovascular Interventional Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurovascular Interventional Devices Market Share by Type: 2024 & 2031
 Figure 4. Embolization Coils Product Picture
 Figure 5. Carotid Stents Product Picture
 Figure 6. Intracranial Stents Product Picture
 Figure 7. Flow Diverters Product Picture
 Figure 8. Intrasaccular Devices Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Neurovascular Interventional Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Neurovascular Interventional Devices Market Share by Application: 2024 & 2031
 Figure 12. Hospitals
 Figure 13. Clinics
 Figure 14. Ambulatory Surgical Centers
 Figure 15. Others
 Figure 16. Global Neurovascular Interventional Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Neurovascular Interventional Devices Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Neurovascular Interventional Devices Sales (2020-2031) & (K Units)
 Figure 19. Global Neurovascular Interventional Devices Average Price (US$/Unit) & (2020-2031)
 Figure 20. Neurovascular Interventional Devices Report Years Considered
 Figure 21. Neurovascular Interventional Devices Sales Share by Manufacturers in 2024
 Figure 22. Global Neurovascular Interventional Devices Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Neurovascular Interventional Devices Players: Market Share by Revenue in Neurovascular Interventional Devices in 2024
 Figure 24. Neurovascular Interventional Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Neurovascular Interventional Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Neurovascular Interventional Devices Sales Market Share by Country (2020-2031)
 Figure 27. North America Neurovascular Interventional Devices Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Neurovascular Interventional Devices Sales Market Share by Country (2020-2031)
 Figure 31. Europe Neurovascular Interventional Devices Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Neurovascular Interventional Devices Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Neurovascular Interventional Devices Revenue Market Share by Region (2020-2031)
 Figure 39. China Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Neurovascular Interventional Devices Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Neurovascular Interventional Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Neurovascular Interventional Devices Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Neurovascular Interventional Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Neurovascular Interventional Devices by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Neurovascular Interventional Devices by Type (2020-2031)
 Figure 61. Global Neurovascular Interventional Devices Price (US$/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Neurovascular Interventional Devices by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Neurovascular Interventional Devices by Application (2020-2031)
 Figure 64. Global Neurovascular Interventional Devices Price (US$/Unit) by Application (2020-2031)
 Figure 65. Neurovascular Interventional Devices Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Bladder Cancer Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38Z13489
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Allergy Skin Test Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12K7064
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Urinary Slings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26L5971
Mon Sep 08 00:00:00 UTC 2025

Add to Cart